Astera Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	490.47	396.29	115.79	79.87
Revenue Growth (YoY)	200.19%	242.24%	44.97%	-
Cost of Revenue	118.88	93.59	35.97	21.19
Gross Profit	371.59	302.7	79.83	58.68
Selling, General & Admin	181.58	217.94	35.92	45.16
Research & Development	211.83	200.83	73.41	73.71
Operating Expenses	393.4	418.77	109.32	118.88
Operating Income	-21.81	-116.07	-29.5	-60.19
Interest & Investment Income	42.17	34.29	6.55	2.61
Pretax Income	20.35	-81.78	-22.95	-57.58
Income Tax Expense	-21.04	1.64	3.31	0.76
Net Income	41.39	-83.42	-26.26	-58.35
Net Income to Common	41.39	-83.42	-26.26	-58.35
Shares Outstanding (Basic)	159	131	37	34
Shares Outstanding (Diluted)	163	131	37	34
Shares Change (YoY)	293.77%	253.51%	8.66%	-
EPS (Basic)	0.26	-0.64	-0.71	-1.71
EPS (Diluted)	0.26	-0.64	-0.71	-1.71
Free Cash Flow	108.17	102.43	-15.48	-39.77
Free Cash Flow Per Share	0.67	0.78	-0.42	-1.16
Gross Margin	75.76%	76.38%	68.94%	73.47%
Operating Margin	-4.45%	-29.29%	-25.47%	-75.36%
Profit Margin	8.44%	-21.05%	-22.68%	-73.05%
Free Cash Flow Margin	22.05%	25.85%	-13.37%	-49.79%
EBITDA	-18.15	-112.91	-27.72	-59.39
EBITDA Margin	-3.70%	-28.49%	-23.94%	-74.35%
D&A For EBITDA	3.67	3.15	1.78	0.81
EBIT	-21.81	-116.07	-29.5	-60.19
EBIT Margin	-4.45%	-29.29%	-25.47%	-75.36%

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q